Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr424 Inhibitors

Olr424 inhibitors represent a fascinating class of chemical compounds that primarily target the Olr424 receptor, a member of the olfactory receptor family. These receptors, often located in the olfactory epithelium, are responsible for detecting odor molecules and initiating the sensory transduction pathway that leads to the perception of smell. Structurally, olfactory receptors belong to the G protein-coupled receptor (GPCR) superfamily, which are characterized by their seven-transmembrane domain structure. The inhibition of Olr424 can lead to significant alterations in the signaling pathways downstream of this receptor. Such inhibitors are typically designed to interact with the receptor's binding site, preventing it from undergoing the conformational changes necessary for signal transduction. This interaction can be highly specific, often involving hydrophobic interactions, hydrogen bonding, and sometimes ionic interactions depending on the nature of the inhibitor and the receptor.

The development and characterization of Olr424 inhibitors involve a combination of techniques, including molecular docking, high-throughput screening, and various forms of spectroscopy. These methods allow researchers to identify key interactions between the inhibitor and the receptor and to optimize the chemical properties of the inhibitors for greater specificity and efficacy. Additionally, structure-activity relationship (SAR) studies play a crucial role in understanding how modifications to the inhibitor's chemical structure affect its binding affinity and inhibitory potency. Understanding these interactions at a molecular level provides valuable insights into the broader mechanisms of olfactory signal transduction and the role of Olr424 in the intricate network of olfactory receptors. Furthermore, the study of Olr424 inhibitors contributes to the broader field of GPCR research, offering potential pathways to explore receptor function and regulation in non-sensory tissues where these receptors might also be expressed.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Azilsartan

147403-03-0sc-503231
sc-503231A
sc-503231B
sc-503231C
sc-503231D
sc-503231E
10 mg
50 mg
100 mg
250 mg
500 mg
1 g
$140.00
$180.00
$230.00
$370.00
$490.00
$781.00
(0)

Angiotensin II receptor blocker, can modulate GPCR signaling indirectly, potentially impacting Olr424.

Cilnidipine

132203-70-4sc-201485
sc-201485A
sc-201485B
10 mg
50 mg
1 g
$74.00
$284.00
$450.00
1
(0)

Dual L/N-type calcium channel blocker, could alter GPCR signaling indirectly through calcium dynamics, impacting Olr424.

Eprosartan

133040-01-4sc-207631
10 mg
$169.00
1
(0)

Angiotensin II receptor antagonist, can influence GPCR signaling indirectly, potentially impacting Olr424.

Gemfibrozil

25812-30-0sc-204764
sc-204764A
5 g
25 g
$66.00
$267.00
2
(2)

Lipid-regulating agent, could modulate GPCR signaling indirectly via lipid metabolism pathways, impacting Olr424.

Pravastatin

81093-37-0sc-222188
50 mg
$408.00
1
(1)

HMG-CoA reductase inhibitor, might indirectly influence GPCR signaling via cholesterol biosynthesis pathways, impacting Olr424.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$72.00
$94.00
8
(1)

Angiotensin II receptor blocker, may indirectly affect GPCR signaling, impacting Olr424.